Advertisement

Topics

Latest "Italfarmaco" News Stories

13:13 EST 18th February 2019 | BioPortfolio

Here are the most relevant search results for "Italfarmaco" found in our extensive news archives from over 250 global news sources.

More Information about Italfarmaco on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Italfarmaco for you to read. Along with our medical data and news we also list Italfarmaco Clinical Trials, which are updated daily. BioPortfolio also has a large database of Italfarmaco Companies for you to search.

Showing "Italfarmaco" News Articles, all 5

Thursday 20th December 2018

Italfarmaco SpA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryItalfarmaco SpA Italfarmaco, a subsidiary of Italfarmaco Holding SpA, is a pharmaceutical and chemical company which develops, manufactures, commercializes, and licences pharmaceutical drugs. The company's products portfolio includes antithrombotics, antihypertensive drugs, Vitamin and mineral supplements, peripheral vasodilators, antineoplastic drugs, antianemics, among others across the t...


Starpharma - Waiting To Shine?

Starpharma (SPHRY.OB), on Thursday, announced that it has licensed the sales and marketing rights of VivaGel BV in the United States to ITF Pharma, a subsidiary of Italfarmaco S.p.A, a privately held European specialty pharmaceutical company.

Wednesday 21st November 2018

Italfarmaco SpA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryItalfarmaco SpA Italfarmaco, a subsidiary of Italfarmaco Holding SpA, is a pharmaceutical and chemical company which develops, manufactures, commercializes, and licences pharmaceutical drugs. The company's products portfolio includes antithrombotics, antihypertensive drugs, Vitamin and mineral supplements, peripheral vasodilators, antineoplastic drugs, antianemics, among others across the t...


Thursday 6th September 2018

ITF Pharma Announces FDA Approval of Tiglutik (riluzole) Oral Suspension for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

BERWYN, Pa., Sept. 6, 2018 /PRNewswire/ -- ITF Pharma, a U.S.-based specialty pharmaceutical company and a subsidiary of Italfarmaco, a privately-held European specialty pharmaceutical company, committed to investing in and commercializing impactful...

Monday 13th August 2018

Italfarmaco SpA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23042018] Prices from USD $250

SummaryItalfarmaco SpA Italfarmaco, a subsidiary of Italfarmaco Holding SpA, is a pharmaceutical and chemical company which develops, manufactures, commercializes, and licences pharmaceutical drugs. The company's products portfolio includes antithrombotics, antihypertensive drugs, Vitamin and mineral supplements, peripheral vasodilators, antineoplastic drugs, antianemics, among others across the t...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks